What is BPC-157?
BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide consisting of 15 amino acids. It is derived from a larger protein found in human gastric juice called Body Protection Compound. First isolated and characterized by Professor Predrag Sikiric at the University of Zagreb, BPC-157 has been the subject of extensive preclinical research since the 1990s, with studies demonstrating remarkable tissue-protective properties across multiple organ systems.
Mechanism of Action
BPC-157 operates through multiple interconnected pathways. It upregulates the expression of growth hormone receptors and promotes the VEGF (vascular endothelial growth factor) pathway, stimulating angiogenesis — the formation of new blood vessels at injury sites. It modulates the nitric oxide (NO) system, influences the FAK-paxillin signaling pathway involved in cell migration, and interacts with the dopaminergic and GABAergic systems. This multi-pathway activity explains its broad range of reported effects across tendon, muscle, bone, gut, and neural tissue.
Published Research Highlights
Over 100 published studies have examined BPC-157 in animal models. Research has documented accelerated healing of transected tendons (Achilles, quadriceps), damaged ligaments, and crushed muscles. Studies show protection against NSAID-induced gastrointestinal damage and alcohol-induced lesions. Neurological research demonstrates effects on dopamine system repair and peripheral nerve regeneration. Bone healing studies show accelerated fracture repair and improved bone-tendon junction recovery.
Research Protocols
Standard research protocols use 250-500mcg of BPC-157 administered subcutaneously once or twice daily. For localized injury research, injection near the affected area is preferred. For systemic effects, abdominal subcutaneous injection is standard. Typical protocol duration is 4-8 weeks. BPC-157 is often stacked with TB-500 in what researchers call the 'Wolverine Stack' for synergistic healing effects — BPC-157 for localized repair and TB-500 for systemic regeneration.
Reconstitution and Storage
BPC-157 is supplied as a lyophilized (freeze-dried) white powder. Reconstitute by slowly injecting 1-2ml of bacteriostatic water into the vial, directing the stream against the glass wall — never directly onto the powder. Gently swirl until dissolved; do not shake. Store reconstituted BPC-157 refrigerated at 2-8°C. Use within 4 weeks of reconstitution. Unreconstituted vials can be stored at -20°C for up to 24 months.
